STEVENS CAPITAL MANAGEMENT LP - ADVERUM BIOTECHNOLOGIES INC ownership

ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 77 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
STEVENS CAPITAL MANAGEMENT LP ownership history of ADVERUM BIOTECHNOLOGIES INC
ValueSharesWeighting
Q3 2017$42,000
-2.3%
11,591
-33.1%
0.00%0.0%
Q2 2017$43,000
+13.2%
17,333
+24.2%
0.00%
+100.0%
Q1 2017$38,000
+8.6%
13,953
+27.5%
0.00%0.0%
Q2 2016$35,00010,9420.00%
Other shareholders
ADVERUM BIOTECHNOLOGIES INC shareholders Q2 2016
NameSharesValueWeighting ↓
Casdin Capital, LLC 420,000$1,134,0000.67%
EcoR1 Capital, LLC 874,447$2,361,0000.60%
VHCP Management II, LLC 280,000$756,0000.31%
683 Capital Management, LLC 350,000$945,0000.15%
AWM Investment Company, Inc. 400,000$1,080,0000.10%
JW Asset Management, LLC 178,654$482,0000.10%
TFS CAPITAL LLC 89,156$241,0000.08%
Rhenman & Partners Asset Management AB 154,006$416,0000.07%
SABBY MANAGEMENT, LLC 282,630$763,0000.04%
Numeric Investors LLC 1,087,967$2,938,0000.03%
View complete list of ADVERUM BIOTECHNOLOGIES INC shareholders